Tianjin Tianyao Pharmaceuticals Co Ltd - Asset Resilience Ratio
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has an Asset Resilience Ratio of 0.00% as of March 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600488 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2015)
This chart shows how Tianjin Tianyao Pharmaceuticals Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 600488 total assets.
Liquid Assets Composition Over Time
This chart breaks down Tianjin Tianyao Pharmaceuticals Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600488 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥128.80K | 0.0% |
| Total Liquid Assets | CN¥128.80K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Tianjin Tianyao Pharmaceuticals Co Ltd maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tianjin Tianyao Pharmaceuticals Co Ltd Industry Peers by Asset Resilience Ratio
Compare Tianjin Tianyao Pharmaceuticals Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
Drug Manufacturers - Specialty & Generic | 2.79% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
Drug Manufacturers - Specialty & Generic | 0.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd (2001–2015)
The table below shows the annual Asset Resilience Ratio data for Tianjin Tianyao Pharmaceuticals Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2015-12-31 | 4.95% | CN¥150.00 Million ≈ $21.95 Million |
CN¥3.03 Billion ≈ $443.85 Million |
+4.90pp |
| 2003-12-31 | 0.05% | CN¥758.82K ≈ $111.04K |
CN¥1.60 Billion ≈ $234.85 Million |
-17.21pp |
| 2002-12-31 | 17.26% | CN¥244.90 Million ≈ $35.84 Million |
CN¥1.42 Billion ≈ $207.65 Million |
+2.70pp |
| 2001-12-31 | 14.55% | CN¥165.06 Million ≈ $24.15 Million |
CN¥1.13 Billion ≈ $165.94 Million |
-- |
About Tianjin Tianyao Pharmaceuticals Co Ltd
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid r… Read more